Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

214.50p
   
  • Change Today:
      1.50p
  • 52 Week High: 254.00
  • 52 Week Low: 176.60
  • Currency: UK Pounds
  • Shares Issued: 219.20m
  • Volume: 310,670
  • Market Cap: £470.19m
  • RiskGrade: 156
  • Beta: 0.02

AMS Overview

We are a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on value for our customers and quality outcomes for patients.
Competitors: Convatec Group, Consort Medical
Registrars: Capita Registrars

Key Personnel

CEO: A Christopher (Chris) Meredith
CFO: Eddie Johnson
Independent Non-Executive Director: Douglas Le Fort
Non-Executive Chairman: Grahame Cook
Non-Executive Dir: Susan Searle

Contact Details

Address: Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, United Kingdom, CW7 3RT
Phone: +44 (0) 1606 863500
Fax: +44 (0) 1606 863600
Website: http://www.admedsol.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB0004536594

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 214.50p
Change Today 1.50p
% Change 0.70 %
52 Week High 254.00
52 Week Low 176.60
Volume 310,670
Shares Issued 219.20m
Market Cap £470.19m
Beta 0.02
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.62% below the market average92.62% below the market average92.62% below the market average92.62% below the market average92.62% below the market average
21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average
Price Trend
0.13% above the market average0.13% above the market average0.13% above the market average0.13% above the market average0.13% above the market average
18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average
Income
84.66% below the market average84.66% below the market average84.66% below the market average84.66% below the market average84.66% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Growth
18.77% below the market average18.77% below the market average18.77% below the market average18.77% below the market average18.77% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 0
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 19-Jun-25 26-Sep-24
Paid 17-Jul-25 25-Oct-24
Amount 1.83p 0.77p

Trades for 13-Jun-2025

Time Volume / Share Price
17:10 25,000 @ 214.50p
16:35 30,327 @ 214.50p
16:35 95 @ 214.50p
16:35 527 @ 214.50p
16:35 575 @ 214.50p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson

Top of Page